Jens W Eckstein

Summary

Publications

  1. ncbi Drug evaluation: Bay-59-8862
    Jens W Eckstein
    Akikoa Pharmaceuticals Inc, 303 Gray Street, Arlington, MA 02476, USA
    IDrugs 7:575-81. 2004

Detail Information

Publications1

  1. ncbi Drug evaluation: Bay-59-8862
    Jens W Eckstein
    Akikoa Pharmaceuticals Inc, 303 Gray Street, Arlington, MA 02476, USA
    IDrugs 7:575-81. 2004
    ..Bayer Corp, under license from Indena SpA, is developing BAY-59-8862, a taxane synthesized from 14beta-hydroxy-10-deacetylbaccatin III, for the potential treatment of cancer...